Shifting Trends in the Causative Mycobacterial Agents of Urinary Tract Infection and their Sensitivity Pattern on Antibiograms in Female Diabetic Patients
Abstract
Background: It is important to avoid using broad spectrum therapy for Urinary Tract Infections as it can contribute to drug resistance. A quick analysis of causative agent and their antibiograms is necessary for cost effective empirical therapy.Objectives: To determine the bacteria profile in urine sample of Urinary Tract Infections in diabetics and to determine the antibiotic susceptibility and sensitivity patterns of those bacteria.Materials and Methods: It was a descriptive type of cross sectional study conducted in of Bacha Khan Medical Complex Swabi for 3 months.Results: A total of 280 samples were collected from the microbiology lab. Out of which 234 were E. coli (83.6%), 16 were Klebsiella Pneumonia (5.7%), 13 were Proteus Mirabilis (4.6%), 10 were Pseudomonas (3.6%), 7 were Enterococcus faecalis (2.5%). Resistance was found for Amoxicillin+clauvulanic acid and Ciprofloxacin, while the organisms were found to be highly sensitive to Ertapenem, Meropenem, Imipenem and 100% sensitive to vancomycin.Conclusion: The most dominant organism was E.coli in culture and sensitivity reports followed by Klebsiella pneumonia then Proteus mirabilis, Pseudomonas and Enterococcus faecalis. Among antibiotics ciprofloxacin and amoxicillin showed least sensitivity in Urinary Tract Infections patients with diabetes and most effective antibiotics in the previous researches (doxycycline and cefepime) also showed alarmingly less sensitivity to uropathogens found in diabetics. The thing that…
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.